BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31204176)

  • 1. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis.
    Huang M; Tailor J; Zhen Q; Gillmor AH; Miller ML; Weishaupt H; Chen J; Zheng T; Nash EK; McHenry LK; An Z; Ye F; Takashima Y; Clarke J; Ayetey H; Cavalli FMG; Luu B; Moriarity BS; Ilkhanizadeh S; Chavez L; Yu C; Kurian KM; Magnaldo T; Sevenet N; Koch P; Pollard SM; Dirks P; Snyder MP; Largaespada DA; Cho YJ; Phillips JJ; Swartling FJ; Morrissy AS; Kool M; Pfister SM; Taylor MD; Smith A; Weiss WA
    Cell Stem Cell; 2019 Sep; 25(3):433-446.e7. PubMed ID: 31204176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.
    Susanto E; Marin Navarro A; Zhou L; Sundström A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Hübner JM; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjö P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20127-20138. PubMed ID: 32747535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gorlin syndrome-induced pluripotent stem cells form medulloblastoma with loss of heterozygosity in
    Ikemoto Y; Miyashita T; Nasu M; Hatsuse H; Kajiwara K; Fujii K; Motojima T; Kokido I; Toyoda M; Umezawa A
    Aging (Albany NY); 2020 May; 12(10):9935-9947. PubMed ID: 32436863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
    Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL
    Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
    Kool M; Jones DT; Jäger N; Northcott PA; Pugh TJ; Hovestadt V; Piro RM; Esparza LA; Markant SL; Remke M; Milde T; Bourdeaut F; Ryzhova M; Sturm D; Pfaff E; Stark S; Hutter S; Seker-Cin H; Johann P; Bender S; Schmidt C; Rausch T; Shih D; Reimand J; Sieber L; Wittmann A; Linke L; Witt H; Weber UD; Zapatka M; König R; Beroukhim R; Bergthold G; van Sluis P; Volckmann R; Koster J; Versteeg R; Schmidt S; Wolf S; Lawerenz C; Bartholomae CC; von Kalle C; Unterberg A; Herold-Mende C; Hofer S; Kulozik AE; von Deimling A; Scheurlen W; Felsberg J; Reifenberger G; Hasselblatt M; Crawford JR; Grant GA; Jabado N; Perry A; Cowdrey C; Croul S; Zadeh G; Korbel JO; Doz F; Delattre O; Bader GD; McCabe MG; Collins VP; Kieran MW; Cho YJ; Pomeroy SL; Witt O; Brors B; Taylor MD; Schüller U; Korshunov A; Eils R; Wechsler-Reya RJ; Lichter P; Pfister SM;
    Cancer Cell; 2014 Mar; 25(3):393-405. PubMed ID: 24651015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis.
    van Essen MJ; Apsley EJ; Riepsaame J; Xu R; Northcott PA; Cowley SA; Jacob J; Becker EBE
    Dis Model Mech; 2024 Feb; 17(2):. PubMed ID: 38411252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional repressor REST drives lineage stage-specific chromatin compaction at
    Dobson THW; Tao RH; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K; Haltom AR; Taylor P; Kogiso M; Qi L; Khatua S; Goldman S; Lulla RR; Fangusaro J; MacDonald TJ; Li XN; Hawkins C; Rajaram V; Gopalakrishnan V
    Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
    Swartling FJ; Savov V; Persson AI; Chen J; Hackett CS; Northcott PA; Grimmer MR; Lau J; Chesler L; Perry A; Phillips JJ; Taylor MD; Weiss WA
    Cancer Cell; 2012 May; 21(5):601-613. PubMed ID: 22624711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.
    Hanaford AR; Archer TC; Price A; Kahlert UD; Maciaczyk J; Nikkhah G; Kim JW; Ehrenberger T; Clemons PA; Dančík V; Seashore-Ludlow B; Viswanathan V; Stewart ML; Rees MG; Shamji A; Schreiber S; Fraenkel E; Pomeroy SL; Mesirov JP; Tamayo P; Eberhart CG; Raabe EH
    Clin Cancer Res; 2016 Aug; 22(15):3903-14. PubMed ID: 27012813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
    Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
    Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.
    Kutscher LM; Okonechnikov K; Batora NV; Clark J; Silva PBG; Vouri M; van Rijn S; Sieber L; Statz B; Gearhart MD; Shiraishi R; Mack N; Orr BA; Korshunov A; Gudenas BL; Smith KS; Mercier AL; Ayrault O; Hoshino M; Kool M; von Hoff K; Graf N; Fleischhack G; Bardwell VJ; Pfister SM; Northcott PA; Kawauchi D
    Genes Dev; 2020 Sep; 34(17-18):1161-1176. PubMed ID: 32820036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
    Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
    Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma.
    Patmore DM; Jassim A; Nathan E; Gilbertson RJ; Tahan D; Hoffmann N; Tong Y; Smith KS; Kanneganti TD; Suzuki H; Taylor MD; Northcott P; Gilbertson RJ
    Dev Cell; 2020 Aug; 54(4):455-470.e5. PubMed ID: 32553121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model for medulloblastoma and basal cell nevus syndrome.
    Corcoran RB; Scott MP
    J Neurooncol; 2001 Jul; 53(3):307-18. PubMed ID: 11718263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.
    Rodriguez-Blanco J; Li B; Long J; Shen C; Yang F; Orton D; Collins S; Kasahara N; Ayad NG; McCrea HJ; Roussel MF; Weiss WA; Capobianco AJ; Robbins DJ
    Clin Cancer Res; 2019 Feb; 25(4):1379-1388. PubMed ID: 30487124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
    Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
    Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First evidence of genotype-phenotype correlations in Gorlin syndrome.
    Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
    J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.